There is genetics and hemoglobin variants and then among one of the principal reasons. Is the life spans of red blood cells the lifetime of red blood cells is is as low as 81 days in diabetics with poor control, and as high as 146 days in people with normal blood sugars.
So some diabetics may have falsely lower a1c, while people with normal blood sugar may show higher a1cs than others non-diabetics.
http://care.diabetesjournals.org/content/27/4/931.full
Abstract
OBJECTIVE—Subjects with decreased erythrocyte survival have an unusually low GHb percentage. The goal of this study was to determine whether hyperglycemia, as reflected by GHb percentage, is associated with decreased erythrocyte survival.
RESEARCH DESIGN AND METHODS—Erythrocyte survival was quantitated in 23 subjects with type 2 diabetes, and these values were correlated with the subjects’ GHb percentage. Erythrocyte survival was determined from the difference between the subjects’ alveolar carbon monoxide (CO) concentration and atmospheric CO concentration. Reticulocyte counts were obtained in 16 subjects.
RESULTS—Although the vast majority of the subjects had erythrocyte life spans that fell within the normal range (123 ± 23 days), there was a highly significant inverse correlation (r = −0.66, P < 0.01) between life span and GHb percentage, with an average decline in life span of 6.9 days for each 1% rise in GHb. The reticulocyte count inversely correlated with erythrocyte life span (r = −0.77, P < 0.01).
CONCLUSIONS—Hyperglycemia, as evidenced by high GHb percentage, is associated with an appreciable decrease in erythrocyte life span. Because GHb appears to be formed over the lifetime of the erythrocyte, this decreased erythrocyte survival suggests that high GHb percentages may systematically underestimate the true degree of hyperglycemia.
Measurements of GHb and its predominant component, HbA1c, have become the routine means of assessing blood glucose control in patients with diabetes. It is well accepted that glucose combines with Hb via a slow irreversible nonenzymatic reaction, the rate of which is determined by the serum glucose concentration (1,2). Thus, GHb percentage can be used as a time-averaged index of the blood glucose concentration to which the Hb has been exposed. However, unusually low GHb percentages are observed in subjects with hemolytic anemia (3–7). Thus, GHb concentration also is a function of the duration of exposure of Hb to blood glucose, i.e., the life span of the erythrocyte. Of particular interest was a study by Peterson et al. (, which showed that the life span of 51Cr-labeled erythrocytes increased in each of seven subjects when their poorly controlled diabetes was brought under control. This observation suggests that hyperglycemia reduces erythrocyte survival, a phenomenon that would cause high GHb levels to consistently underestimate the severity of hyperglycemia. The small sample size (seven subjects) in the study by Peterson et al. ( presumably is attributable to the time-consuming and cumbersome nature of 51Cr labeling studies, which require repeated blood samplings over a multiweek period to obtain a single erythrocyte survival measurement. We recently described a simple and rapid technique to quantitate erythrocyte survival based on measurements of the concentration of carbon monoxide (CO) in expired air (9,10). In the present study, this technique was used to study the relationship between GHb percentage and erythrocyte survival.
So some diabetics may have falsely lower a1c, while people with normal blood sugar may show higher a1cs than others non-diabetics.
http://care.diabetesjournals.org/content/27/4/931.full
Abstract
OBJECTIVE—Subjects with decreased erythrocyte survival have an unusually low GHb percentage. The goal of this study was to determine whether hyperglycemia, as reflected by GHb percentage, is associated with decreased erythrocyte survival.
RESEARCH DESIGN AND METHODS—Erythrocyte survival was quantitated in 23 subjects with type 2 diabetes, and these values were correlated with the subjects’ GHb percentage. Erythrocyte survival was determined from the difference between the subjects’ alveolar carbon monoxide (CO) concentration and atmospheric CO concentration. Reticulocyte counts were obtained in 16 subjects.
RESULTS—Although the vast majority of the subjects had erythrocyte life spans that fell within the normal range (123 ± 23 days), there was a highly significant inverse correlation (r = −0.66, P < 0.01) between life span and GHb percentage, with an average decline in life span of 6.9 days for each 1% rise in GHb. The reticulocyte count inversely correlated with erythrocyte life span (r = −0.77, P < 0.01).
CONCLUSIONS—Hyperglycemia, as evidenced by high GHb percentage, is associated with an appreciable decrease in erythrocyte life span. Because GHb appears to be formed over the lifetime of the erythrocyte, this decreased erythrocyte survival suggests that high GHb percentages may systematically underestimate the true degree of hyperglycemia.
Measurements of GHb and its predominant component, HbA1c, have become the routine means of assessing blood glucose control in patients with diabetes. It is well accepted that glucose combines with Hb via a slow irreversible nonenzymatic reaction, the rate of which is determined by the serum glucose concentration (1,2). Thus, GHb percentage can be used as a time-averaged index of the blood glucose concentration to which the Hb has been exposed. However, unusually low GHb percentages are observed in subjects with hemolytic anemia (3–7). Thus, GHb concentration also is a function of the duration of exposure of Hb to blood glucose, i.e., the life span of the erythrocyte. Of particular interest was a study by Peterson et al. (, which showed that the life span of 51Cr-labeled erythrocytes increased in each of seven subjects when their poorly controlled diabetes was brought under control. This observation suggests that hyperglycemia reduces erythrocyte survival, a phenomenon that would cause high GHb levels to consistently underestimate the severity of hyperglycemia. The small sample size (seven subjects) in the study by Peterson et al. ( presumably is attributable to the time-consuming and cumbersome nature of 51Cr labeling studies, which require repeated blood samplings over a multiweek period to obtain a single erythrocyte survival measurement. We recently described a simple and rapid technique to quantitate erythrocyte survival based on measurements of the concentration of carbon monoxide (CO) in expired air (9,10). In the present study, this technique was used to study the relationship between GHb percentage and erythrocyte survival.